Year | Detail |
1984 |
QIAGEN (originally Diagen) was born as a spin-out from the Heinrich-Heine University in Dusseldorf. |
1986 |
It revolutionized molecular biology by introducing the first "Plasmid-Kit". |
1996 |
Introduced the BioRobot 9600, its first bench-top workstation, which automates purification technologies. |
1999 |
Joint venture with Becton, Dickenson and Company is established. |
2004 |
Company QIAamp becomes the world’s first standalone product for sample preparation to receive the CE-mark. |
2006 |
Established Asia regional headquarters in Shanghai. |
2007 |
QIAGEN merged with Digene Corp. |
2009 |
Acquired DxS Ltd. |
2010 |
Launched QIAsymphony RGQ, a highly flexible modular automation platform covering entire laboratory workflows. |
2010 |
QIAGEN acquired a new detection technology for Point of Need. |
2011 |
Expansion in Asia with new subsidiaries in India and Taiwan. |
2012 |
FDA approval for its KRAS test. |
2013 |
Acquired Ingenuity Systems and CLC Bio. |
2014 |
QIAGEN’s technologies play a key role in the fight against the devastating Ebola outbreak in Africa. |
2015 |
Launches the GeneReader NGS System. |
2016 |
Acquires Exiqon A/S. |
2018 |
Partners with NeuMoDx Molecular Inc. |
2022 |
QIAGEN acquires majority stake in enzymes provider BLIRT S.A. |
2023 |
QIAGEN completes acquisition of Verogen. |